VasoDynamics Receives Global Health & Pharma Biotechnology 2023 Award Gallery VasoDynamics Receives Global Health & Pharma Biotechnology 2023 Award By Chloe Atkinson|2024-07-25T13:04:56+00:00April 12th, 2023|News| Read More
VasoDynamics Receives UK MHRA-REC Approval On NG11-2 Phase Ib Clinical Trial Gallery VasoDynamics Receives UK MHRA-REC Approval On NG11-2 Phase Ib Clinical Trial By Chloe Atkinson|2024-11-13T13:00:29+00:00January 24th, 2023|Clinical Development, News, NG11| Read More
VasoDynamics files UK patent for Radiotherapy-Induced Oral Mucositis (RIOM) Clinical Trial Methodology Gallery VasoDynamics files UK patent for Radiotherapy-Induced Oral Mucositis (RIOM) Clinical Trial Methodology By Chloe Atkinson|2024-11-13T13:00:47+00:00December 22nd, 2022|Clinical Development, News| Read More
VasoDynamics submits UK Clinical Trial Application for NG11-2 Gallery VasoDynamics submits UK Clinical Trial Application for NG11-2 By Chloe Atkinson|2024-11-13T13:00:58+00:00October 21st, 2022|Clinical Development, News, NG11| Read More
VasoDynamics establishes Clinical and Scientific Advisory Board Gallery VasoDynamics establishes Clinical and Scientific Advisory Board By Chloe Atkinson|2024-11-13T13:01:11+00:00July 30th, 2022|Corporate Development, News| Read More
VasoDynamics selects clinical trial sites across the UK and appoints Chief Investigator Gallery VasoDynamics selects clinical trial sites across the UK and appoints Chief Investigator By Chloe Atkinson|2024-11-13T13:01:49+00:00June 30th, 2022|Corporate Development, News| Read More
VasoDynamics files global patent (PCT) for NG11-2 platform formulation and production Gallery VasoDynamics files global patent (PCT) for NG11-2 platform formulation and production By Chloe Atkinson|2024-11-13T13:01:41+00:00March 5th, 2022|Clinical Development, News, NG11| Read More
VasoDynamics strengthens Board and management team with key appointments Gallery VasoDynamics strengthens Board and management team with key appointments By Chloe Atkinson|2024-11-13T13:02:04+00:00January 10th, 2022|Corporate Development, News| Read More
VasoDynamics attracts £1.9m from new investors Gallery VasoDynamics attracts £1.9m from new investors By Chloe Atkinson|2024-11-13T13:02:22+00:00November 30th, 2021|Corporate Development, News| Read More
VasoDynamics completes MHRA advisory meeting for NG11-2 clinical development Gallery VasoDynamics completes MHRA advisory meeting for NG11-2 clinical development By Chloe Atkinson|2024-11-13T13:02:35+00:00September 21st, 2021|Clinical Development, News, NG11| Read More
